Table 5.

Summary of model outcomes

Model	LYs	ICER	QALYs	Costs		NMBs	Others
Name				Direct costs	Indirect costs
NIDDM [20]	√	√	√	√
DCEM [12]	√	√	√	√			The number of discounted QALYs
Archimedes [19]	√	√	√	√			Expected number of cases
CDM [27]	√	√	√	√	√		Acceptability curve and/or NHBs
UKPDS-OM1 [21]	√		√	√ (not classified direct or indirect)
Michigan [9]				√			Health utility scores
Cardiff [10]			√	√ (not classified direct or indirect)			Total number of clinical events
ODEM [11]	√	√	√	√
Sheffield [22]	√	√	√	√			CEAC
UKPDS-OM2 [28]	√		√	√ (not classified direct or indirect)
ECHO [24]	√	√	√	√		√	Mean survival
IHE [23]	√	√	√	√	√	√
COMT [26]	√	√	√	√			DALYs
COMT [26]	√	√	√	√

LYs life years, ICER incremental cost-effectiveness ratios, QALYs quality-adjusted life years, NMBs net monetary benefits, CEAC cost-effectiveness acceptability curve, DALYs disability-adjusted life

years